Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 1,070,000 shares, a growth of 5.9% from the October 31st total of 1,010,000 shares. Currently, 2.7% of the shares of the stock are […]
Key Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their...
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark...
HOLLISTON, Mass., Nov. 20, 2023 -- Harvard Bioscience, Inc. today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday...
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce its 12th Annual Discovery One-on-One Investor Conference to be...